1,707
Participants
Start Date
August 30, 2018
Primary Completion Date
July 26, 2019
Study Completion Date
December 17, 2019
MenACWY liquid
At visit 1 (day 1), each subject will receive a single dose of the investigational MenACWY liquid vaccine (GSK3536820A) aged for approximately 24 months in Phase 1 of the study (subjects randomized to study arm ACWY\_Liq24) or vaccine aged for 30 months in Phase 2 of the study (subjects randomized to study arm ACWY\_Liq30), administered by intramuscular injection in the deltoid of the non-dominant arm.
MenACWY
At visit 1 (day 1), each subject will receive a single dose of the MenACWY vaccine in the Phase1 of the study (subjects randomized to study arm ACWY\_1) or in phase 2 of the study (subjects randomized to study arm ACWY\_2), administered by intramuscular injection in the deltoid of the non-dominant arm.
GSK Investigational Site, Bellville
GSK Investigational Site, Tallinn
GSK Investigational Site, Tallinn
GSK Investigational Site, Rosiers-d'Égletons
GSK Investigational Site, Eskişehir
GSK Investigational Site, Madrid
GSK Investigational Site, Pori
GSK Investigational Site, Tampere
GSK Investigational Site, Durango
GSK Investigational Site, Izmir
GSK Investigational Site, Tours
GSK Investigational Site, Seville
GSK Investigational Site, Nantes
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Quart de Poblet, Valencia
GSK Investigational Site, Angers
GSK Investigational Site, Tartu
GSK Investigational Site, Oulu
GSK Investigational Site, Mérida
GSK Investigational Site, Moscow
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Murmansk
GSK Investigational Site, Gatchina
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Salvador
GSK Investigational Site, Natal
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Tallinn
GSK Investigational Site, Barcelona
GSK Investigational Site, Valencia
GSK Investigational Site, Espoo
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Nice
GSK Investigational Site, Tomsk
GSK Investigational Site, Pretoria
GSK Investigational Site, Barcelona
GSK Investigational Site, Centelles (Barcelona)
GSK Investigational Site, L'Hospitalet de Llobregat
GSK Investigational Site, La Roca Del Valles (Barcelona)
GSK Investigational Site, Vic/ Barcelona
Lead Sponsor
GlaxoSmithKline
INDUSTRY